Press Release | Sat Nov 2, 2013 9:00am EDT

BMS Submits First All-Oral, Interferon-Free and Ribavirin-Free Treatment Regimen for Regulatory Review in Japan for Patients with Chronic Hepatitis C Infection

* Reuters is not responsible for the content in this press release.